RT Journal Article
SR Electronic
T1 Endometrial cancer: molecular classification and future treatments
JF BMJ Medicine
JO bmjmed
FD BMJ Publishing Group Ltd
SP e000152
DO 10.1136/bmjmed-2022-000152
VO 1
IS 1
A1 Corr, Bradley
A1 Cosgrove, Casey
A1 Spinosa, Daniel
A1 Guntupalli, Saketh
YR 2022
UL http://bmjmedicine.bmj.com/content/1/1/e000152.abstract
AB The treatment for endometrial cancer is rapidly evolving with the development of molecular analysis and novel strategies. Surgical resection, cytotoxic chemotherapy, endocrine or hormonal treatment, and radiation have been the staples of treatment for decades. However, precision based approaches for tumours are rapidly becoming a part of these strategies. Biomarker driven treatments are now a part of primary and recurrent treatment algorithms. This review aims to describe the current state of molecular analysis and treatment for endometrial cancer as well as to elucidate potential approaches for the near future.